Surviving Pneumonia

NCT ID: NCT03795662

Last Updated: 2021-04-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

2500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-01-07

Study Completion Date

2038-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study aims to explore risk factors for poor prognosis among patients admitted with community-acquired pneumonia (CAP). During a 5-year study period, all patients (aged ≥ 18 years) admitted with CAP at North Zealand Hospital will be invited for inclusion. Questionnaires, anthropometric measures, laboratory tests, and biomaterials will be collected at admission, daily during admission, at discharge and at follow-up. The main clinical outcomes of the study consist of deaths and development of diabetes.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Community-acquired Pneumonia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Community-acquired pneumonia

Adults over 18 years old admitted with confirmed community-acquired pneumonia.

No intervention

Intervention Type OTHER

Obervational

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

No intervention

Obervational

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Infiltrate on chest radiograph plus one or more of the following:

* Fever (temperature, ≥38.0°C)
* Hypothermia (\<35.0°C),
* New cough with or without sputum production
* Pleuritic chest pain
* Dyspnea
* Altered breath sounds on auscultation.

Exclusion Criteria

* Patients unable to give informed consent
* Patients unwilling to give informed consent
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Nordsjaellands Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Birgitte Lindegaard Madsen

Associated professor, MD, PhD

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Birgitte Lindegaard, Assoc. Prof

Role: PRINCIPAL_INVESTIGATOR

Nordsjaellands Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Pulmonary and Infectious Diseases, Nordsjællands Hospital

Hillerød, , Denmark

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Denmark

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Camilla Ryrsø, MSc

Role: CONTACT

+4548293250

Maria Hegelund, MSc

Role: CONTACT

+4548293250

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Birgitte Lindegaard, MD, PhD

Role: primary

References

Explore related publications, articles, or registry entries linked to this study.

Ryrso CK, Hegelund MH, Dungu AM, Faurholt-Jepsen D, Pedersen BK, Ritz C, Krogh-Madsen R, Lindegaard B. Association between Barthel Index, Grip Strength, and Physical Activity Level at Admission and Prognosis in Community-Acquired Pneumonia: A Prospective Cohort Study. J Clin Med. 2022 Oct 27;11(21):6326. doi: 10.3390/jcm11216326.

Reference Type DERIVED
PMID: 36362554 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Surviving Pneumonia

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.